Lusutrombopag-d13 Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Lusutrombopag-d13 is the labelled analogue of Lusutrombopag (L474985), a newly discovered thrombopoietin receptor agonist used in the treatment of patients with chronic ITP.

Lusutrombopag-d13 Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

Lusutrombopag-d13 Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
TargetMol Chemicals Inc.	+17819995354	marketing@targetmol.com	United States	19939	58
TLC Pharmaceutical Standards Ltd.	18012923235; 18012923235	chinasales04@tlcstandards.com.cn	China	7824	58

---

• Lusutrombopag-d13